Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · Real-Time Price · USD

13.84

-0.35 (-2.47%)

At close: Mar 13, 2026, 4:00 PM EDT

13.90

+0.06 (0.43%)

After-hours: Mar 13, 2026, 4:26 PM EDT

Tenax Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	23.71	6.79	5.01	5.68	7.58
Research & Development	32.67	12.71	3.23	5.38	25.15
Total Operating Expenses	56.39	19.49	8.23	11.05	32.73
Operating Income	-56.39	-19.49	-8.23	-11.05	-32.73
Interest Income	3.82	1.91	0.48	-	-
Interest Expense	-	0.02	0.02	-0	-0
Other Non-Operating Income (Expense)	-0.03	0	0.06	-0.01	-0.25
Total Non-Operating Income (Expense)	3.79	1.94	0.57	-0.01	-0.26
Pretax Income	-52.6	-17.56	-7.66	-11.07	-32.98
Net Income	52.6	17.6	7.71	-11.05	-32.47
Net Income to Common	52.6	17.6	7.71	-11.05	-32.47
Net Income Growth	198.82%	128.27%	-	-	-
Shares Outstanding (Basic)	39	15	0	0	1
Shares Outstanding (Diluted)	39	15	0	0	1
Shares Change (YoY)	156.80%	6046.87%	1250.92%	-98.21%	694.04%
EPS (Basic)	-1.34	-1.15	-31.04	-600.71	-31.56
EPS (Diluted)	-1.34	-1.15	-31.04	-600.71	-31.56
Free Cash Flow	-35.8	-14.81	-5.9	-11.39	-10.86
Free Cash Flow Per Share	-0.91	-0.97	-23.76	-619.25	-10.56
EBITDA	-56.39	-19.49	-8.23	-10.94	-32.62
EBIT	-56.39	-19.49	-8.23	-11.05	-32.73

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q